Analystreport

Health Catalyst, Inc. (NASDAQ: HCAT) had its price target raised by analysts at Stifel Nicolaus from $5.00 to $5.50. They now have a "hold" rating on the stock.

Health Catalyst, Inc - Common stock  (HCAT) 
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm Check Earnings Report